Liver toxicity with ribociclib in a patient with metastatic hormone receptor positive postmenopausal breast cancer.

Sozer Karadagli, Sumru; Gursoy, Pinar

Sozer Karadagli, Sumru; Gursoy, Pinar.

Affiliation

Sozer Karadagli S; Department of Pharmaceutical Toxicology, Ege University Faculty of Pharmacy, Izmir, Turkey.
Gursoy P; Tulay Aktas Oncology Hospital, Ege University School of Medicine, Izmir, Turkey.

J Oncol Pharm Pract ; 30(2): 404-407, 2024 Mar.

Article in En | MEDLINE | ID: mdl-37899576

Subject(s)

Aminopyridines; Breast Neoplasms; Drug-Related Side Effects and Adverse Reactions; Purines; Female; Humans; Aminopyridines/adverse effects; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Breast Neoplasms/pathology; Cysteine/therapeutic use; Drug-Related Side Effects and Adverse Reactions/drug therapy; Liver; Postmenopause; Purines/adverse effects; Receptor, ErbB-2

Key words

Breast cancer; NAC; adverse reactions; case; liver toxicity; ribociclib

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purines / Breast Neoplasms / Drug-Related Side Effects and Adverse Reactions / Aminopyridines Limits: Female / Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2024 Document type: Article Affiliation country: Turkey Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google